Product Identifiers under the Drug Supply Chain Security Act - Questions and Answers: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 3, 2021
June 3, 2021
d3880c89-0e09-41de-baae-d56590db8510
Related Documents
Questions and Answers on Biosimilar Development and the BPCI Act Guidance for Industry: Guidance for Industry
Guidance DocumentSeptember 17, 2021Center for Drug Evaluation and Research
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
Product Development Under the Animal Rule
Guidance DocumentOctober 2, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox